BioFishency

Company Overview

Snapshot

Founded in March 2013 by Cobi Levanon and Igal Magen, BioFishency operates with 1–10 employees. The company has raised $3.5 million across two funding rounds from two investors. In March 2019, BioFishency secured a funding round from The Trendlines Group and Aqua-Spark.

Business overview

BioFishency develops all-in-one water treatment systems for land-based aquaculture, addressing challenges such as limited water availability and toxic ammonia buildup from fish excretion. Its technology aims to improve fish survival, growth, and reproduction by enabling increased production in ponds and reduced water usage in tanks. The system supports extensive, intensive, and recirculated aquaculture methods, allowing fish farms to enhance output using existing infrastructure. BioFishency operates within the Agriculture & Food Technologies sector, focusing on sustainable farming and water solutions.

Strategic signal

In January 2026, BioFishency ceased operations, indicating a significant and definitive shift in its corporate status. This event signals to investors and innovation teams that the company is no longer an active player in the aquaculture water treatment market, prompting a re-evaluation of its past strategic initiatives and market impact.

Company Intelligence Q&A

What is BioFishency's primary focus?

BioFishency develops all-in-one water treatment systems specifically designed for land-based aquaculture, aiming to improve fish survival and growth by managing water quality and reducing ammonia buildup.

When was BioFishency founded?

BioFishency was founded in March 2013.

Who are the co-founders of BioFishency?

BioFishency was co-founded by Cobi Levanon and Igal Magen.

What was a notable achievement for BioFishency in 2018?

BioFishency won first prize at the Fishtech awards in November 2018.

What is the current operational status of BioFishency?

BioFishency ceased to operate in January 2026.